TickerFactsScreenerDevelopers

Seres Therapeutics, Inc. (MCRB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $6.21M2013: $1.65M2014: $114.19M2015: $73.93M2016: $54.54M2017: $36.09M2018: $85.82M2019: $65.13M2020: $116.05M2021: $180.00M2022: $163.03M2023: $127.97M2024: $30.79M2025: $45.77M$45.77M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$45.77M+48.6%
2024$30.79M-75.9%
2023$127.97M-21.5%
2022$163.03M-9.4%
2021$180.00M+55.1%
2020$116.05M+78.2%
2019$65.13M-24.1%
2018$85.82M+137.8%
2017$36.09M-33.8%
2016$54.54M-26.2%
2015$73.93M-35.3%
2014$114.19M+6803.6%
2013$1.65M-73.4%
2012$6.21M—